Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Sanofi
02 9Bayer AG
03 4Novo Nordisk
04 7Takeda Pharmaceutical
01 10KIT
02 17POWDER FOR SOLUTION
01 27Schedule D
01 6ADYNOVATE
02 7ELOCTATE
03 4ESPEROCT
04 4JIVI
05 5KOVALTRY
06 1OBIZUR
01 27Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 250UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430290
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 500UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430304
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 750UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430312
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 1000UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430320
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1500UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430339
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2000UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430347
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 3000UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430355
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 250UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451441
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451468
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451476
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 2000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2451484
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 3000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2451492
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED)
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging : 500
Approval Date :
Application Number : 2481766
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED)
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2481774
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED)
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2481782
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED)
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 3000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2481790
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490064
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490072
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT) PORCINE SEQUENCE
Brand Name : OBIZUR
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/ML
Packaging : 1ML RECONST. IN 3ML VIAL
Approval Date :
Application Number : 2447401
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED
Brand Name : ADYNOVATE
Dosage Form : KIT
Dosage Strength : 2000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2459078
Regulatory Info : Schedule D
Registration Country : Canada
